Where Will Tilray Brands Be in 3 Years?
Its future depends on how effectively it can navigate cannabis legalization in potential major markets.
3 Unstoppable Stocks That Don't Care About the Bear Market
When the market is falling, this trio keeps rising.
Prediction: This Bear Market Will Test Your Resolve In (At Least) 3 Ways
Your portfolio is counting on you to pass the tests.
3 Things About Sundial Growers That Smart Investors Know
Not a whole lot is going right, but it isn't as bad as it might look.
Is There any Hope for Teladoc Stock in 2023?
Its recent performance leaves a lot to be desired.
Buying Shares of These 2 Monster Stocks on the Dip Could Be a Genius Move
They're the undisputed leaders of their markets.
Should You Really Be Buying Beaten-Down Growth Stocks Right Now?
Now's a great time to invest in companies with the potential to grow significantly in the long term.
3 Reasons Why AbbVie Stock Could Be Approaching a Make or Break Moment
It won't be able to rely on Humira for growth for much longer.
2 Red Flags and 2 Green Flags for Tilray Stock
It's having trouble at home, but it could soon get a huge gift from European regulators.
3 Things Most Investors Don't Know About Warren Buffett's Investing Style
There's a lot more to value investing than picking companies with evergreen business models.
Could This Unknown Stock Beat Moderna in 2023?
Vaxart is still in the coronavirus vaccine race, even though its competitors remain very far ahead.
2 Growth Stocks That Are Unapologetically Crushing the Bear Market
There's more than one factor driving recent outperformance of these shares.
3 Early Signs This Crushed Growth Stock Might Be in a Turnaround
Aurora Cannabis still has a long way to go, but a few key things are going right.
3 Things the Smartest Investors Do When the Market Is Crazy
They stay focused on the long term and act accordingly.
Do These 3 New Moneymakers for AstraZeneca Make It a Buy?
Cranking out new medicines is business as usual, but these three could be big earners.
Is Abbott Laboratories a Buy?
This stock rewards investors who have patience.
2 Potential Headwinds and 2 Potential Tailwinds for InMode Stock in August
InMode's margin is under pressure from multiple points, but it probably won't matter.
3 Key Questions That Pfizer Will Answer This Week
Paxlovid's performance will be the most important issue to clarify.
2 Reasons Why DexCom Stock Could Be a Smart Buy This Week
Its global ambitions are poised to drive further returns.
3 No-Brainer Warren Buffett Stocks That Will Undeniably Profit from the Bear Market
These unstoppable companies can succeed in pretty much any economic condition.